We partner with the media to inform the public of the global human crisis.
Latest News
-
June 15, 2018
Indivior Is Granted Temporary Restraining Order... -
June 15, 2018
Indivior Responds to Generic SUBOXONE® Approvals and Dr. Reddy’s Launch “At-Risk”... -
May 31, 2018
Indivior Receives Subpoena from California Department of Insurance... -
May 25, 2018
Indivior Announces Regulatory Submission to Australia’s Therapeutic Goods Administration (TGA) for SUBLOCADE™ (Buprenorphine Extended-Release) Injection for the Treatment of Opioid Dependence... -
May 17, 2018
Result of AGM...
Global Media Contacts
Email: IndiviorMediaContacts@indivior.com
Phone: +1 804-594-0836
UK Media Contacts
Tulchan Communications LLP
85 Fleet Street
London
EC4Y 1AE
Indivior@Tulchangroup.com
Phone: +44 (020) 7353 4200
Upcoming Events
Media Kit
The Online Press Kit is designed to help media research our company for background information or follow-up stories. Please visit the links below to learn more.
About Indivior PLC – An overview of Indivior, including our worldwide locations and key products
Board of Directors – Biographies of Indivior’s Board
The Indivior PLC Pipeline – Information about the Indivior R&D efforts and progress of medicines in the pipeline